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During the past few years much attention has been given to the 
study of vitamin  C  metabolism in  health  and disease.  What  has 
rendered this problem so attractive to laboratory workers and clini- 
cians alike is the fact that vitamin C is not only significant as an acces- 
sory factor in nutrition, absence of which causes characteristic degen- 
erative lesions in various tissues, but that ascorbic acid has come to be 
recognized as a physiological substance of great biochemical potency 
which seems to play an important part in the regulation of certain cell 
functions concerned with the mechanism of normal defense against 
microbial injury (1).  This is borne out by numerous observations on 
increased  susceptibility  to  bacterial  infections and  intoxications in 
C-deficient animals and proven more directly by the discovery that 
the vitamin C stores are often severely depleted during the progress 
of  an  infectious process.  The latter  data  are  based on vitamin  C 
assays of the tissues of experimentally infected animals, as well as on 
the demonstration of C  deficiencies in patients suffering from infec- 
tious diseases as determined by the urinary excretion following oral 
administration of large doses of ascorbic acid. 
As might be expected, attempts have been made to compensate  for 
this loss of vitamin C by increasing the intake; and evidence is begin- 
ning to accumulate which suggests that the administration of vitamin 
C during the course of certain infections and intoxications in man and 
animals may be followed by a reduction in severity of the pathological 
process.  It is  an open question whether such resistance-enhancing 
effects are due to an indirect stimulation of the physiological defense 
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mechanism of the cells or whether ascorbic acid is capable of destroy- 
ing directly certain bacteria, toxins, and viruses in vivo, as has deafly 
been demonstrated to occur when such infectious agents are brought 
together with the vitamin in vitro.  While changes in vitamin C levels, 
occurring as they do in the wake of many infectious processes, do not 
necessarily  signify  any  causal  relationship  to  susceptibility,  it  has 
seemed possible that vitamin C metabolism may assume a  particular 
significance in  those  infectious diseases  which  are  normally charac- 
terized by wide variations in individual resistance.  This would seem 
to apply especially if such infections or intoxications should prove to 
respond favorably to therapeutic doses of ascorbic acid as appears to 
be  true  for diphtheria,  tuberculosis,  and poliomyelitis (2),  to  quote 
only the best studied examples.  It is for this reason that we have un- 
dertaken a  detailed investigation of the vitamin C  content of monkey 
tissues in experimental poliomyelitis, the object of this study being to 
compare  the  vitamin  C  levels  of  various  representative  tissues  in 
normal monkeys with those of poliomyelitic monkeys and of infected 
animals in which an attempt had been made to lessen the severity of 
the  infection by parenteral  administration of vitamin  C  during the 
incubation period of the disease (2). 
Methods 
The work was planned to provide  as fair a  basis  of comparison as possible 
between  the vitamin C levels of normal and poliomyelitic monkeys which had 
received no injections of ascorbic acid and those of normal and infected animals 
which had been injected daily for 2 weeks with doses of ascorbic acid ranging from 
5 to 100 mg.  All animals were kept on the same general balanced dietary r6gime, 
which consisted of rice, bread, and milk and included an ample amount of bananas, 
oranges, and lettuce as a source of vitamin C.  While the quality of the diet was 
therefore roughly adequate, no strict control of the quantitative individual intake 
of food could be obtained since the monkeys were sitting in groups of 10 to 15 
in large cages.  All monkeys were of approximately  similar weight, ranging from 
2300 to 2800 gun., and were sexually immature.  The tissues studied were particu- 
larly brain,  cord, and suprarenal;  but we have also run numerous titrations of 
other organs  such as liver,  spleen,  gonads,  kidney, and intestines.  Few tests 
were done with blood and spinal  fluid since it was soon discovered that these 
fluids contained none or so little vitamin C that the amounts could not be accu- 
rately measured.  Normal  monkeys were sacrificed from time to time together 
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the fact that this study extended over a  period of several months  (January to 
May)  and  that  the  animals  were  received  from  different  shipments.  Polio- 
myelitic monkeys, if prostrated,  were killed at the height of paralysis  in  order 
to exclude any gross error due to inanition. 
The monkeys (Maca~us rhesus) were  killed by intracardiac  injection of air, 
and the tissues immediately removed and titrated for vitamin C according to the 
modified method of Bessey and King (3).  This method measures only the reduced 
vitamin  C  present  in the  tissues,  and is based on the fact  that  vitamin  C, in 
strongly acidic solutions  (of pH  2-3),  will  reduce very rapidly  the  indophenol 
reagent to its colorless  base.  The dye is blue in alkaline and pink in acid solu- 
tion; the end-point of the titration is reached when the acid extract turns a pink 
color.  The tissues are weighed accurately and then ground with sand in a mixture 
of 8 per cent trichloracetic and 2 per cent metaphosphoric acid in a glass mortar 
until a very fine homogeneous suspension is obtained.  This suspension is centri- 
fuged and the supernatant poured into a volumetric flask.  The residue is again 
extracted with acid and centrifuged; the supernatants are then brought up to a 
volume of 25  or 50 cc.,  depending on the  expected  concentration of C  in  the 
tissues.  Aliquot portions of the extract are titrated against sodium 2-6 dichloro- 
benzenone indophenol (Eastman Kodak P 3453).  The dye is usually made up so 
that 1 cc. of the solution is the equivalent of 0.1  to 0.3 rag. of vitamin C.  The 
indicator is standardized against an acid solution of crystalline vitamin C, which 
in turn has been standardized against a 0.01 N solution of iodine.  The titrations 
are  completed within about 30 seconds and the first pink color that appears is 
taken as the end-point.  A blank of the acid mixture alone is always run for any 
given  volume  of extract.  Other  substances  in  tissue  extracts  will  reduce  the 
indicator even in strongly acid solution, although more slowly than vitamin C (4). 
For this reason a rapid end-point (5 to 30 seconds) is considered fairly accurate; 
however difficulties  are often encountered when tissue extracts (e.g., liver, kidney) 
contain substances  which reduce  the  dye almost  as rapidly as does vitamin  C. 
The end-point is such that although it is rapidly fading, another drop of indicator 
is not immediately reduced by the extract as it would be if vitamin C were still 
present.  The  results,  with  correction for the  blank,  are  calculated  as  rag.  of 
vitamin C per gin. of tissue.  The experimental error lies between 5 and 10 per 
cent.  While the use of the indophenol reagent, therefore, may not give absolute 
values for the C content of tissues,  we agree with others that it is accurate enough 
for comparative purposes, especially since the titration values against the dye are 
found  to  correlate  closely  with  the  values  obtained  by  the  biological  assay 
method (5). 1 
1 Reversibly oxidized vitamin C may be brought back to the reduced state by 
the passage of HzS through the solution for a  length  of time  with  subsequent 
removal of the H~S by N  or CO2.  Since substances other than dehydroascorbic 
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RESULTS 
A total of 123 monkeys was killed for tissue titration.  This number 
is made up of four main groups which are listed as follows: (1)  normal 
monkeys which had not received any vitamin C parenterally,  (2) nor- 
mal monkeys which had been injected  subcutaneously with  5  or 25 
rag. of ascorbic acid daily for a period of 2 weeks, (3) control monkeys 
which had not received vitamin C and showed various degrees of paral- 
ysis following intracerebral inoculation with poliomyelitis virus, and 
(4)  vitamin  C-treated  monkeys  which  had  received  subcutaneous 
injections of 5 to 100 mg. of ascorbic acid daily for a period of 2 weeks 
following intracerebral  infection with  poliomyelitis virus.  This  last 
group  is  further  subdivided  into  monkeys  which  survived  without 
paralysis following C  treatment  and  those which  succumbed to  the 
disease  in  spite  of  treatment.  The  results  obtained  in  the  several 
groups of monkeys will now be discussed individually. 
Group /.--Normal  monkeys.  There  were  5  normal  monkeys  in 
this group.  These were sacrificed from time to time during the course 
of this investigation after being kept on the ordinary feeding schedule 
for a  period of at least 2 weeks.  The average C levels found in the 
central nervous system and suprarenals,  expressed in rag. per gin.  of 
tissue, were as follows: 0.08 for brain, 0.07 for cord, and 0.43 for supra- 
renal. 
Group 2.--Normal  C-prepared  monkeys.  This  group  included  3 
monkeys all of which were sacrificed on the day following the last in- 
jection of vitamin  C.  The average  C levels found in nervous tissue 
and the suprarenals of these animals were markedly higher than those 
observed for normal monkeys, i.e., 0.15 for brain,  0.10 for cord,  and 
0.75  for  suprarenal. 
Group 3.--Poliomyelitic control monkeys.  This group comprised a 
total of 24 animals serving as untreated controls for vitamin C-treated 
monkeys which had been infected simultaneously.  Of these 24 ani- 
mals  11  were completely prostrated  by quadriplegia;  the  remaining 
use of this method was not practical we have run only a few such tests.  In those 
instances where this method was used we found no changes in our values that 
could not be accounted for by probable errors in technique.  It seems, therefore, 
likely that most of the vitamin was present in these tissues in the reduced form. CLAUS  W.  JUNGEBLUT  AND  ROSE  R.  FEINER  483 
13 were partially paralyzed to various extents.  The  11  completely 
paralyzed animals were killed at  the height of paralysis and the 13 
partially paralyzed animals at different stages of their convalescence, 
which varied from 3to 4 weeks (7 animals) to 6 to 10 weeks (6 animals) 
following the onset of paralysis.  The C levels found in animals killed 
at the height of paralysis as well as in the early stage of convalescence 
were uniformly low, average values of 0.07  and 0.06 being obtained 
for brain,  0.05  and 0.07  for  cord,  and 0.27  for suprarenal.  These 
figures were  slightly below those of corresponding normal monkey 
tissues.  Somewhat higher average figures were observed in animals 
which were allowed to recover up to 10 weeks, i.e., 0.13 for brain, 0.10 
for cord, and 0.53 for suprarenal.  It will be noted that these values 
were slightly above the C levels of normal monkeys. 
Group 4.  C-treated infected monkeys.  This group is by far the 
largest, including a total of 91 monkeys in which an attempt had been 
made to influence the course of experimental poliomyelitis by paren- 
teral administration of vitamin C during the incubation period.  The 
total number of animals in this group is divided into two subgroups, 
the first subgroup representing 58 animals which developed paralysis 
in spite of treatment, while the second subgroup contained 33 animals 
which had survived without showing any evidence of paralytic symp- 
toms. 
The paralyzed animals, if prostrated by quadriplegia, were killed 
at the height of paralysis (35 animals) and if partially paralyzed were 
sacrificed at 3 to 4 weeks (19 animals) or at 5 to 10 weeks (4 animals) 
following the onset of paralysis.  Titration of the  tissues of these 
C-treated paralyzed animals showed average C values distinctly higher 
than those observed for untreated poliomyelitic controls, running from 
0.13  to 0.14 for brain, from 0.09 to 0.11  for cord, and from 0.51  to 
0.79 for suprarenal.  These values were therefore either very slightly 
below or practically identical with the levels of normal C-prepared 
monkeys.  There was little if any secondary rise in the figures con- 
comitant with the progress of convalescence in this group, probably 
because the initial values were already  high. 
Interesting results were obtained in the second subgroup with C- 
treated animals which had escaped paralysis.  These animals were 
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the day of infection (21 animals) or as late as 6 weeks thereafter (12 
animals).  The average figures for those killed at the earlier period 
showed unusually high C levels in all tissues examined, i.e.,  0.15 for 
brain, 0.13  for cord, and 0.90  for suprarenal.  However, when such 
animals  had  been  permitted to  live  until  6  weeks  after  infection, 
these hypernormal values had again returned to figures which were 
only slightly above the normal average, i.e.,  0.13 in brain, 0.09 in cord, 
and 0.44 in suprarenal. 
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A summary of these titrations will be found in Table I, while Chart 1 
gives a  comparison of the C levels, tissue for tissue, in the different 
groups of  animals. 
As was mentioned before, we have also run numerous C titrations on 
tissues other than the central nervous system and the suprarenals. 
These determinations have yielded results, closely comparable to those 
reported above, i.e.,  high or low levels of C in the brain, cord, and the 
suprarenals were usually reflected by high or low levels in the spleen, 
liver, gonads, and intestines.  These data are therefore not reproduced CLAUS W. JUNGEBLUT AND ROSE R. ]?EINER  48.5 
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in detail.  However, we are giving in Table II and in Chart 2 the re- 
sults of the titration of all tissues examined for normal monkeys and 
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CHAleT 2.  Vitamin C content of the tissues of normal and vitamin C-prepared 
monkeys. 
normal  C-prepared  monkeys  because  they  demonstrate  clearly  the 
increase in all values following preparation  with  vitamin  C.  These CLAUS  W.  JUNGEBLUT  AND  ROSE  R.  :FEINER  487 
increases are most marked in the liver, kidney, and intestine, and are 
followed by those in the spleen and brain.  The cord seems to par- 
ticipate only to a very modest extent in this process of C assimilation. 
DISCUSSION 
The data presented in this paper offer information on the concen- 
trations of vitamin C  that  are present in various tissues of normal 
rhesus monkeys and the extent to which such concentrations are sub- 
ject to alteration by the parenterai administration of ascorbic acid. 
They are also helpful in explaining the results obtained with vitamin 
C  therapy in  experimental poliomyelitis. 
It is well known that different animal species, on the basis of their 
susceptibility to experimental scurvy, may be divided into those which 
are  capable  of synthesizing their own vitamin C  and those which 
depend upon dietary intake to supply this nutritional factor.  There 
is well documented evidence to show that species of the first category, 
such as rats, rabbits,  dogs, cats, and cattle, carry higher C levels in 
all tissues than man and the guinea pig, which belong to the second 
category (6).  Although the monkey's susceptibility to experimental 
scurvy is well established, figures relating to the C content of monkey 
tissues, with the exception of the blood (7), have been wanting.  The 
results of our titrations show that the C levels of the monkey fail in 
line  with  those of other  non-synthesizing species.  If the brain or 
suprarenal are taken as representative organs, the following series of 
C  values, expressed in mg. per gm. of tissue, is therefore obtained: 
rat: 0.30 rag. (brain), 3 to 6 rag. (suprarenal); rabbit: 0.20 mg. (brain), 
2  to 3  rag.  (suprarenal);  cat: 0.20 mg.  (brain),  1 mg. (suprarenal); 
dog: 0.19  rag.  (brain),  0.9  mg.  (suprarenai);  guinea pig:  0.14  mg. 
(brain), 0.3 to 0.7 mg.  (suprarenal); man: 0.15  rag.  (brain), 0.5 mg. 
(suprarenal);  and  monkey: 0.08  mg.  (brain),  0.4  mg.  (suprarenai). 
The values are slightly higher in very young and slightly lower in very 
old animals.  Similar ratios are found in other tissues. 
Since the amount of vitamin C found in the tissues depends upon 
the amount of ascorbic acid taken in, both orally and parenterally, C 
titrations must always be interpreted in terms of dietary intake.  How 
sensitive an indicator the tissue C level is of variations in diet, other 
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this work.  For a  short time some monkeys were fed more oranges 
than usual, with the result that the C values ran significantly higher. 
On the other hand, some monkeys which were sacrificed shortly after 
having been received from the dealer, showed considerably lower C 
levels in all tissues.  These animals were therefore excluded from tabu- 
lation in this study.  We have also found some evidence for the pres- 
ence of a  slight seasonal increase in tissue C  levels of all monkeys, 
normal,  treated,  and  controls,  beginning with  the month of June. 
For this reason we have omitted all titrations carried out after that 
date.  Even when due allowance has been made for variables which 
might affect the titration values, there still remains an extraordinary 
variability in the figures for  animals within  a  given group, partic- 
ularly in the suprarenal, as indicated by the extent of the so called 
median range from which the averages were computed. 
The data obtained in this study have an important bearing on the 
nature of the therapeutic effect of vitamin C in experimental polio- 
myelitis.  There is some indication that the amounts of C present in 
nervous tissues and in the suprarenal tend to diminish slightly during 
the progress of the infection.  This is shown more clearly by contrast- 
ing the C  levels of normal monkeys with those of poliomyelitic con- 
trois  at  the height of paralysis or during early convalescence than 
by  a  comparison of the  figures obtained in  normal and  paralyzed 
animals which carried an  additional load of vitamin C.  As far  as 
the suprarenal is concerned, this loss of C  during the disease is in 
accord with scattered preliminary observations previously reported 
(8).  However, it appears that the loss of C that occurs during polio- 
myelitic infection in the monkey is not nearly as striking as the C 
depletion observed in diphtheritic intoxication (9).  In favor of the 
assumption that the lower C levels in paralytic monkeys are due to a 
temporary derangement of C metabolism produced by the disease and 
not referable to chance factors is the fact that poliomyelific monkeys 
show a  distinct tendency for a  return to  normal and even slightly 
hypernormal C levels as convalescence progresses.  It is dif6cult, of 
course, to exclude with certainty that this secondary increase may not 
be the result of better adjustment to laboratory conditions.  How- 
ever, the data recently published by Torrance (10),  who observed a 
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administration of sublethal doses of diphtheria toxin, suggest at least 
the possibility that recovery from poliomyelitis may be accompanied 
with a mobilization of vitamin C.  Of particular interest is the fact 
that unusually high C levels were uniformly encountered in monkeys 
which had  escaped paralysis  following treatment  with  vitamin  C, 
when such animals were examined in the early stages of their survival. 
Since these values were even higher than those obtained in normal 
animals after C preparation, they probably represent the aggregate 
effect of  increased intake  and  increased assimilation  of  vitamin  C 
during the infection.  The artificial character of this high C satura- 
tion is dearly indicated by its brief duration, there being a return to 
normal levels in non-paralytic survivors which had not been examined 
until 6  weeks following the date of infection.  Comparable figures 
have only been found in a small number of monkeys, not included in 
this work, which had passed through a non-paralytic febrile episode 
following intracerebral injection of poliomyelitis virus in combination 
with certain inactivating agents.  It would seem likely therefore that 
the  therapeutic  effect  observed  after  parenteral  administration of 
vitamin C consists essentially in changing the frank paralytic type of 
the disease into the non-paralytic abortive type which fails to induce 
specific  immunity to reinfection (11). 
In conclusion it can be stated that distinctly hypernormal C levels 
in  the  central  nervous  system  and  in  the  suprarenals  have  been 
observed  only  in  association  with  resistance  to  the  disease.  The 
possibility suggests itself, therefore, that there may be a  certain de- 
limiting threshold concentration of vitamin  C  in the tissues above 
which the monkey is protected and below which it  is  unprotected 
against the production of nerve cell damages by the virus.  As this 
concentration begins to drop following discontinuance of C adminis- 
tration there is evidently a return to the state of susceptibility as indi- 
cated by the considerable number of animals which develop delayed 
paralysis between 14 days and 47 days following infection (12).  We 
have no explanation to offer why only a certain percentage of infected 
monkeys following C admluistration are capable of reaching a critical 
concentration of vitamb~  C  in the tissues  and succeed in escaping 
paralysis permanently.  But  our  data  suggest  that  the  success or 
failure of C treatment in experimental poliomyelitis may be intimately 490  VITAMIN  C IN  TISSUES IN  POLIOMYELITIS 
connected With the extent to which the ascorbic acid is utilized by the 
organism. 
SUMMARY AND  CONCLUSIONS 
1.  The concentrations of reduced ascorbic acid present in the tissues 
of normal rhesus  monkeys are of a  magnitude in keeping with the 
values found for other  animal  species which are incapable of  syn- 
thesizing vitamin  C.  These concentrations are  subject  to  distinct 
increase by prolonged parenteral administration of ascorbic acid. 
2.  The amounts of vitamin C  present in  nervous tissue  and the 
suprarenals of monkeys, paralyzed as the result of poliomyelitis in- 
fection, are slightly below the normal average when examined at the 
height of paralysis  or in  early  convalescence.  The  figures show  a 
tendency for a  return to normal or slightly hypernormal levels con- 
comitant with the progress of convalescence. 
3.  Vitamin C titrations of the tissues of monkeys which had received 
parenteral injections of ascorbic acid during the incubation period of 
poliomyelitic infection  give  different  results  according  to  whether 
such animals develop paralysis or survive without paralytic symptoms. 
In paralyzed C-treated monkeys the vitamin C levels are practically 
identical  with  those  of  normal  C-prepared  monkeys.  Markedly 
higher values, however, are obtained with non-paralytic survivors in 
the early stages of their survival.  As the period of survival lengthens 
normal figures prevail again. 
4.  The  data  are  discussed in  their relationship to  the  success or 
failure of vitamin C  therapy in experimental poliomyelitis. 
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